convulex 500 mg gastroresistentne pehmekapsel
g.l. pharma gmbh - valproehape - gastroresistentne pehmekapsel - 500mg 100tk
convulex 300 mg gastroresistentne pehmekapsel
g.l. pharma gmbh - valproehape - gastroresistentne pehmekapsel - 300mg 100tk
convulex 300 mg/ml suukaudsed tilgad, lahus
g.l. pharma gmbh - valproehape - suukaudsed tilgad, lahus - 300mg 1ml 100ml 1tk
convulex 150 mg gastroresistentne pehmekapsel
g.l. pharma gmbh - valproehape - gastroresistentne pehmekapsel - 150mg 100tk
convulex siirup
g.l. pharma gmbh - valproehape - siirup - 50mg 1ml 100ml 1tk
zynlonta
swedish orphan biovitrum ab - loncastuximab tesirine - lymphoma, large b-cell, diffuse; lymphoma, b-cell - antineoplastilised ained - zynlonta as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl), after two or more lines of systemic therapy.
convulex retard 300mg toimeainet prolongeeritult vabastav tablett
g.l. pharma gmbh - valproehape - toimeainet prolongeeritult vabastav tablett - 300mg 100tk; 300mg 50tk
valproate sodium sandoz 300mg toimeainet prolongeeritult vabastav tablett
sandoz pharmaceuticals d.d. - valproehape - toimeainet prolongeeritult vabastav tablett - 300mg 30tk; 300mg 200tk; 300mg 50tk; 300mg 100tk
convulex retard 500mg toimeainet prolongeeritult vabastav tablett
g.l. pharma gmbh - valproehape - toimeainet prolongeeritult vabastav tablett - 500mg 50tk
valproate sodium sandoz 500mg toimeainet prolongeeritult vabastav tablett
sandoz pharmaceuticals d.d. - valproehape - toimeainet prolongeeritult vabastav tablett - 500mg 30tk; 500mg 100tk; 500mg 20tk; 500mg 200tk; 500mg 90tk; 500mg 60tk; 500mg 50tk